Antimicrobial Characteristics of Bacteria Obtained from Various Body Site Infections in Patients Located in Al-Bayda City

• Khadeejah Al-hour

  Department of Microbiology and Immunology ,faculty of Medicine ,Omar Al-Mukhtar University, Libya

  Author

 This retrospective study (2020–2021) in Al-Bayda, Libya, analyzed 177 bacterial isolates from various body site infections. Predominant bacteria included Staphylococci (61), Streptococci (46), and Escherichia coli (36). Most isolates were multidrug-resistant (MDR). Staphylococci were susceptible only to amikacin, meropenem, and tetracycline but resistant to 16 antibiotics. Streptococci were susceptible to doxycycline and meropenem but resistant to 17 antibiotics. E. coli showed susceptibility to doxycycline, meropenem, and tetracycline but high resistance to 16 antibiotics. Other Gram-negative bacteria (Klebsiella, Proteus, Neisseria) also exhibited high MDR rates, with Proteus resistant to 18 antibiotics. The findings highlight severe antibacterial resistance in the region,and this is limiting treatment options.

Aftab, Friha. (2016). Antibiotics as controlled medicines

.

Celi, Leo Anthony G, Fraser, Hamish SF, Nikore, Vipan, Osorio, Juan Sebastian, & Paik, Kenneth. (2017). Global health informatics: Principles of eHealth and mHealth to improve quality of care: MIT Press

Mazel, Didier, & Mobashery, Shahriar. (2012). Antibiotics as physiological stress inducers and bacterial response to the challenge. Current opinion in microbiology, 15(5), 553-554

.

Naylor, Nichola R, Atun, Rifat, Zhu, Nina, Kulasabanathan, Kavian, Silva, Sachin, Chatterjee, Anuja, . . . Robotham, Julie V. (2018). Estimating the burden of antimicrobial resistance: a systematic literature review. Antimicrobial.

Pokharel, Sunil, Raut, Shristi, & Adhikari, Bipin. (2019). Tackling antimicrobial resistance in low-income and middle-income countries (Vol. 4, pp. e002104): BMJ Specialist Journals.

Schiavetti, B, Wynendaele, E, & De Spiegeleer, B. (2018). CIOMS Guide to vaccine safety communication. WHO Drug Inf, 32(1).

Copyright (c) 2025 Khadeejah Al-hour (Author)

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Copyright of the articles Published by Almukhtar Journal of Science (MJSc) is retained by the author(s), who grant MJSc a license to publish the article. Authors also grant any third party the right to use the article freely as long as its integrity is maintained and its original authors and cite MJSc as the original publisher. Also, they accept the article remains published by the MJSc website (except in the occasion of a retraction of the article).